Jazz Pharmaceuticals JAZZ Income Tax Reconciliation Change In Enacted Tax Rate
Income Tax Reconciliation Change In Enacted Tax Rate at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's income tax reconciliation change in enacted tax rate.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's income tax reconciliation change in enacted tax rate?
- Jazz Pharmaceuticals (JAZZ) reported income tax reconciliation change in enacted tax rate of $234.5K in Q4 2024.
- How has Jazz Pharmaceuticals's income tax reconciliation change in enacted tax rate changed year-over-year?
- Jazz Pharmaceuticals's income tax reconciliation change in enacted tax rate increased by 255.0% year-over-year, from -$151.25K to $234.5K.
- What is the long-term trend for Jazz Pharmaceuticals's income tax reconciliation change in enacted tax rate?
- Over 3 years (2021 to 2024), Jazz Pharmaceuticals's income tax reconciliation change in enacted tax rate has grown at a -84.7% compound annual growth rate (CAGR), from $261.66M to $938K.
- What does income tax reconciliation change in enacted tax rate mean?
- The impact of government-mandated changes in tax rates on the company's deferred tax balances.
- How do you interpret income tax reconciliation change in enacted tax rate?
- An increase in tax rates generally results in a one-time charge or benefit depending on the net deferred tax position.
- How does income tax reconciliation change in enacted tax rate compare across companies?
- Standard regulatory adjustment reported by all firms during tax reform periods.